InvestorsHub Logo

OhManIDied

11/19/14 11:10 AM

#17609 RE: Drugdoctor #17599

Don't forget that they are going to receive kickbacks from the factors once they hit a milestone collection and again after 18months of collections.

The company believe the factor rate is closer to 35% for them, but are recording 20% as the gains aren't yet realized.

This will cause a transfer of ~20-30% of the interest expenses from the liabilities to the assets. This move from negative to positive will have a double impact!

So that is reducing $2M-$3M from libilities and adding $2M-$3M to CASH assets = $4M-$6M net change on earnings - added to the bottom line.

Interest expense-(10,959,086)

neophyte184

11/19/14 11:17 AM

#17614 RE: Drugdoctor #17599

Anyone not understanding the implications here for PXYN as a long play, aren't paying attention.